Found 2 bookmarks
Custom sorting
Low dose rapamycin in a study was shown to increase interferon antiviral response. Participants reported lower rates of infections for 1 year. Improved T cell response. This drug is being trialed for . Amy Proal PhD 🧵
Low dose rapamycin in a study was shown to increase interferon antiviral response. Participants reported lower rates of infections for 1 year. Improved T cell response. This drug is being trialed for . Amy Proal PhD 🧵
“Low dose rapamycin in a study was shown to increase interferon antiviral response. Participants reported lower rates of infections for 1 year. Improved T cell response. This drug is being trialed for #LongCovid. Amy Proal PhD @microbeminded2 🧵”
#rapamycin#antiviral#Treatment#Long Covid#Video
·x.com·
Low dose rapamycin in a study was shown to increase interferon antiviral response. Participants reported lower rates of infections for 1 year. Improved T cell response. This drug is being trialed for . Amy Proal PhD 🧵
UT researchers say they found an antibody that protects against all COVID-19 variants
UT researchers say they found an antibody that protects against all COVID-19 variants
A team of researchers, led by folks at the University of Texas at Austin, believe they’ve found an antibody that protects against all COVID-19 variants.
A team of researchers, led by folks at the University of Texas at Austin, believe they’ve found an antibody that protects against all COVID-19 variants.
#antibodies#variants#treatment#VIdeo
·kxan.com·
UT researchers say they found an antibody that protects against all COVID-19 variants